ArticleJournal for immunotherapy of cancer2020

Correction: 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.